Cambrex Corporation is an innovative life sciences company providing products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.
We offer a variety of technology-driven products and services for generic and branded pharmaceuticals:
- Advanced intermediates
- Drug delivery products
- Custom development and manufacturing
Our R&D and cGMP manufacturing facilities are located in the US, Europe and India. We are committed to operating our facilities with the highest standards of:
- Regulatory compliance
- Environmental, health and safety guidelines
Cambrex Corporation is headquartered in East Rutherford, NJ, USA and is listed on the NYSE (CBM).